This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: Class IV

January 2009 Br J Cardiol 2009;16(Suppl 1):S10-S12

The optimal time to treat PAH patients

BJCardio editorial team

Abstract

Figure 1: NYHA Functional Class at presentation in pulmonary arterial hypertension (PAH) Despite greater awareness of PAH in recent years and the availability of targeted therapies, the majority of patients are at an advanced symptomatic stage by the time they are diagnosed.3 A French registry of 674 patients has highlighted that 75% of patients were in New York Heart Association (NYHA) Class III or IV at presentation (figure 1).3 Clinical investigations to date have focused largely on these more compromised patient populations. However, some recent studies have included patients in the early symptomatic stages of the disease. This is suppor

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now